Iron deficiency in Russia heart failure patients. Observational cross-sectional multicenter study
Aim To evaluate the prevalence of iron deficiency (ID) in Russian patients with heart failure (HF).Material and methods Iron metabolism variables were studied in 498 (198 women, 300 men) patients with HF. Data were evaluated at admission for HF (97 %) or during an outpatient visit (3 %). ID was determined according to the European Society of Cardiology Guidelines.Results 83.1 % of patients had ID; only 43.5 % of patients with ID had anemia. Patients with ID were older: 70.0 [63.0;79.0] vs. 66.0 years [57.0;75.2] (p=0.009). The number of patients with ID increased in parallel with the increase in HF functional class (FC). Among patients with ID, fewer people were past or current alcohol users (p=0.002), and a greater number of patients had atrial fibrillation (60.1 vs. 45.2 %, p=0.016). A multiple logistic regression showed that more severe HF (HF FC) was associated with a higher incidence of ID detection, whereas past alcohol use was associated with less pronounced ID. An increase in N-terminal pro-brain natriuretic peptide (NT-proBNP) by 100 pg/ml was associated with an increased likelihood of ID (odds ratio, 1.006, 95 % confidence interval: 1.002-1.011, p=0.0152).Conclusion The incidence rate of HF patients is high in the Russian Federation (83.1 %). Only 43.5 % of these patients had anemia. The prevalence of ID in the study population increased with increases in HF FC and NT-proBNP.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
Kardiologiia - 62(2022), 5 vom: 31. Mai, Seite 4-8 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
Mareev, V Yu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
114471-18-0 |
|---|
| Anmerkungen: |
Date Completed 14.06.2022 Date Revised 15.06.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.18087/cardio.2022.5.n2083 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342138081 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342138081 | ||
| 003 | DE-627 | ||
| 005 | 20231226013412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.18087/cardio.2022.5.n2083 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1140.xml |
| 035 | |a (DE-627)NLM342138081 | ||
| 035 | |a (NLM)35692168 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Mareev, V Yu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Iron deficiency in Russia heart failure patients. Observational cross-sectional multicenter study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.06.2022 | ||
| 500 | |a Date Revised 15.06.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Aim To evaluate the prevalence of iron deficiency (ID) in Russian patients with heart failure (HF).Material and methods Iron metabolism variables were studied in 498 (198 women, 300 men) patients with HF. Data were evaluated at admission for HF (97 %) or during an outpatient visit (3 %). ID was determined according to the European Society of Cardiology Guidelines.Results 83.1 % of patients had ID; only 43.5 % of patients with ID had anemia. Patients with ID were older: 70.0 [63.0;79.0] vs. 66.0 years [57.0;75.2] (p=0.009). The number of patients with ID increased in parallel with the increase in HF functional class (FC). Among patients with ID, fewer people were past or current alcohol users (p=0.002), and a greater number of patients had atrial fibrillation (60.1 vs. 45.2 %, p=0.016). A multiple logistic regression showed that more severe HF (HF FC) was associated with a higher incidence of ID detection, whereas past alcohol use was associated with less pronounced ID. An increase in N-terminal pro-brain natriuretic peptide (NT-proBNP) by 100 pg/ml was associated with an increased likelihood of ID (odds ratio, 1.006, 95 % confidence interval: 1.002-1.011, p=0.0152).Conclusion The incidence rate of HF patients is high in the Russian Federation (83.1 %). Only 43.5 % of these patients had anemia. The prevalence of ID in the study population increased with increases in HF FC and NT-proBNP | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Peptide Fragments |2 NLM | |
| 650 | 7 | |a Natriuretic Peptide, Brain |2 NLM | |
| 650 | 7 | |a 114471-18-0 |2 NLM | |
| 700 | 1 | |a Begrambekova, Yu L |e verfasserin |4 aut | |
| 700 | 1 | |a Mareev, Yu V |e verfasserin |4 aut | |
| 700 | 1 | |a Kobalava, Zh D |e verfasserin |4 aut | |
| 700 | 1 | |a Karapetyan, L V |e verfasserin |4 aut | |
| 700 | 1 | |a Galochkin, S A |e verfasserin |4 aut | |
| 700 | 1 | |a Kazakhmedov, E R |e verfasserin |4 aut | |
| 700 | 1 | |a Lapshin, A A |e verfasserin |4 aut | |
| 700 | 1 | |a Garganeeva, A A |e verfasserin |4 aut | |
| 700 | 1 | |a Kuzheleva, E A |e verfasserin |4 aut | |
| 700 | 1 | |a Efremushkina, A А |e verfasserin |4 aut | |
| 700 | 1 | |a Kiseleva, E V |e verfasserin |4 aut | |
| 700 | 1 | |a Barbarash, O L |e verfasserin |4 aut | |
| 700 | 1 | |a Pecherina, T B |e verfasserin |4 aut | |
| 700 | 1 | |a Galyavich, A S |e verfasserin |4 aut | |
| 700 | 1 | |a Galeeva, Z M |e verfasserin |4 aut | |
| 700 | 1 | |a Baleeva, L V |e verfasserin |4 aut | |
| 700 | 1 | |a Koziolova, N A |e verfasserin |4 aut | |
| 700 | 1 | |a Veklich, A S |e verfasserin |4 aut | |
| 700 | 1 | |a Duplyakov, D V |e verfasserin |4 aut | |
| 700 | 1 | |a Maksimova, M N |e verfasserin |4 aut | |
| 700 | 1 | |a Yakushin, S S |e verfasserin |4 aut | |
| 700 | 1 | |a Smirnova, E A |e verfasserin |4 aut | |
| 700 | 1 | |a Sedykh, E V |e verfasserin |4 aut | |
| 700 | 1 | |a Shaposhnik, I I |e verfasserin |4 aut | |
| 700 | 1 | |a Makarova, N A |e verfasserin |4 aut | |
| 700 | 1 | |a Zemlyanukhina, A A |e verfasserin |4 aut | |
| 700 | 1 | |a Skibitsky, V V |e verfasserin |4 aut | |
| 700 | 1 | |a Fendrikova, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Skibitsky, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Spiropulos, N A |e verfasserin |4 aut | |
| 700 | 1 | |a Seredenina, E M |e verfasserin |4 aut | |
| 700 | 1 | |a Orlova, Ya A |e verfasserin |4 aut | |
| 700 | 1 | |a Eruslanova, K A |e verfasserin |4 aut | |
| 700 | 1 | |a Kotovskaya, Yu V |e verfasserin |4 aut | |
| 700 | 1 | |a Tkacheva, O N |e verfasserin |4 aut | |
| 700 | 1 | |a Fedin, M A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Kardiologiia |d 1961 |g 62(2022), 5 vom: 31. Mai, Seite 4-8 |w (DE-627)NLM000007153 |x 0022-9040 |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2022 |g number:5 |g day:31 |g month:05 |g pages:4-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18087/cardio.2022.5.n2083 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2022 |e 5 |b 31 |c 05 |h 4-8 | ||